Truist Financial’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-8,158
Closed -$810K 2493
2019
Q3
$810K Sell
8,158
-1,411
-15% -$134K 0.01% 491
2019
Q2
$885K Sell
9,569
-249
-3% -$23.6K 0.02% 479
2019
Q1
$926K Sell
9,818
-994
-9% -$86.9K 0.02% 471
2018
Q4
$693K Sell
10,812
-558
-5% -$41.2K 0.01% 505
2018
Q3
$1.02M Sell
11,370
-4,104
-27% -$363K 0.02% 475
2018
Q2
$1.23M Sell
15,474
-2,455
-14% -$204K 0.02% 438
2018
Q1
$1.6M Sell
17,929
-1,988
-10% -$191K 0.03% 401
2017
Q4
$2.08M Sell
19,917
-3,452
-15% -$390K 0.04% 361
2017
Q3
$3.41M Sell
23,369
-587
-2% -$80K 0.07% 283
2017
Q2
$3.11M Buy
23,956
+4,194
+21% +$514K 0.06% 304
2017
Q1
$2.46M Sell
19,762
-2,212
-10% -$265K 0.05% 335
2016
Q4
$2.54M Sell
21,974
-57
-0.3% -$6.35K 0.05% 331
2016
Q3
$2.3M Sell
22,031
-409
-2% -$44.3K 0.05% 346
2016
Q2
$2.21M Sell
22,440
-2,668
-11% -$276K 0.05% 354
2016
Q1
$2.51M Sell
25,108
-1,605
-6% -$165K 0.07% 289
2015
Q4
$3.2M Sell
26,713
-9,988
-27% -$1.16M 0.08% 254
2015
Q3
$3.97M Sell
36,701
-12,983
-26% -$1.61M 0.1% 230
2015
Q2
$5.75M Buy
49,684
+2,203
+5% +$252K 0.16% 163
2015
Q1
$5.47M Sell
47,481
-2,720
-5% -$325K 0.16% 163
2014
Q4
$5.62M Buy
50,201
+13,227
+36% +$1.39M 0.16% 158
2014
Q3
$3.5M Buy
36,974
+23,966
+184% +$2.16M 0.11% 213
2014
Q2
$1.12M Sell
13,008
-1,536
-11% -$117K 0.03% 365
2014
Q1
$1.01M Sell
14,544
-1,556
-10% -$123K 0.03% 374
2013
Q4
$1.36M Sell
16,100
-562
-3% -$44.5K 0.04% 316
2013
Q3
$1.28M Sell
16,662
-660
-4% -$46.3K 0.05% 307
2013
Q2
$1.01M Buy
+17,322
New +$1.04M 0.04% 320

Other funds holding CELG

Truist Financial's CELG Position: Q4 2019 in Review

Truist Financial sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 8,158 shares — an estimated $810K sold.

Truist Financial first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $5.75M in Q2 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Truist Financial reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Truist Financial sold 8,158 Celgene Corp shares in Q4 2019, an estimated $810K.
  • Truist Financial first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Truist Financial's Celgene Corp position peaked at $5.75M in Q2 2015.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Truist Financial's 13F filing for Q4 2019, filed 14 Feb 2020.